article thumbnail

SGLT-2 inhibitor, cardiovascular risk and outcome in patients with comorbidity of hypertension and diabetes [Cardiovascular disease]

Annals of Family Medicine

Sodium-glucose transporter 2 (SGLT-2) inhibitors have been proved to decrease the cardiovascular adverse events in several large randomized controlled trials (RCTS), but evidence limited to patients with type 2 diabetes and ASCVD. Outcome Measures Changes of China-PAR score and cardiovascular hospitalization events.

article thumbnail

Our Anxiety Epidemic: How to Stop Fearing the Future

Priority Physicians

Many of us know where our meals come from, have sufficient clothing, enjoy roofs over our heads, access heating and air conditioning, use reliable transportation, and receive effective medications. The quality of life for Americans is far superior to that of the king of England 200 years ago and vastly superior to his subjects.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Middle to Older Age Latinas Experiences Across the Cervical Cancer Continuum: Screening, Diagnosis, Treatment and Impact [Health care disparities]

Annals of Family Medicine

Participants were recruited via electronic healthcare records, community tabling events, and social media efforts. About 90% were either currently or formerly undocumented, 2/3 spoke Spanish, 2/3 made <$50,000 annually, and 1/3 reported inadequate transportation. Our Community Advisory Board (CAB) guided this work.

Diagnosis 130
article thumbnail

Stories We Tell Each Other to Heal: Ricky Leiter, Alexis Drutchas, & Emily Silverman

GeriPal

It was like kind of a co op with this common space that different groups could rent for events and meetings and things like that. And I was interviewing candidates for our clinical fellowship and interviewed Alexis, who had been like family medicine doc before, done all kinds of cool things. Ricky 11:23 Yeah.

IT 107